{"id":"https://openalex.org/W2103376969","doi":"https://doi.org/10.1093/rheumatology/key051","title":"Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab","display_name":"Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab","publication_year":2002,"publication_date":"2002-12-31","ids":{"openalex":"https://openalex.org/W2103376969","doi":"https://doi.org/10.1093/rheumatology/key051","mag":"2103376969","pmid":"https://pubmed.ncbi.nlm.nih.gov/12509641"},"language":"en","primary_location":{"id":"doi:10.1093/rheumatology/key051","doi":"https://doi.org/10.1093/rheumatology/key051","is_oa":false,"landing_page_url":"https://doi.org/10.1093/rheumatology/key051","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Lara D. Veeken","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064491408","display_name":"Antonio Marchesoni","orcid":"https://orcid.org/0000-0002-0714-5902","observed_orcids":["https://orcid.org/0000-0002-0714-5902"]},"institutions":[{"id":"https://openalex.org/I4210086830","display_name":"Ospedale San Paolo","ror":"https://ror.org/0026m8b31","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I4210086830"]},{"id":"https://openalex.org/I4210113750","display_name":"Istituto Ortopedico Gaetano Pini","ror":"https://ror.org/02brpaf34","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210113750"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"A Marchesoni","raw_affiliation_strings":["Rheumatology, G. Pini Orthopaedic Institute","S. Paolo Hospital, Internal Medicine I, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology, G. Pini Orthopaedic Institute","institution_ids":["https://openalex.org/I4210113750"]},{"raw_affiliation_string":"S. Paolo Hospital, Internal Medicine I, Milan, Italy","institution_ids":["https://openalex.org/I4210086830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077362641","display_name":"Marco Arreghini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086830","display_name":"Ospedale San Paolo","ror":"https://ror.org/0026m8b31","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I4210086830"]},{"id":"https://openalex.org/I4210113750","display_name":"Istituto Ortopedico Gaetano Pini","ror":"https://ror.org/02brpaf34","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210113750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M Arreghini","raw_affiliation_strings":["Rheumatology, G. Pini Orthopaedic Institute","S. Paolo Hospital, Internal Medicine I, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology, G. Pini Orthopaedic Institute","institution_ids":["https://openalex.org/I4210113750"]},{"raw_affiliation_string":"S. Paolo Hospital, Internal Medicine I, Milan, Italy","institution_ids":["https://openalex.org/I4210086830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057835205","display_name":"Benedetta Panni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086830","display_name":"Ospedale San Paolo","ror":"https://ror.org/0026m8b31","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I4210086830"]},{"id":"https://openalex.org/I4210113750","display_name":"Istituto Ortopedico Gaetano Pini","ror":"https://ror.org/02brpaf34","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210113750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"B Panni","raw_affiliation_strings":["Rheumatology, G. Pini Orthopaedic Institute","S. Paolo Hospital, Internal Medicine I, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology, G. Pini Orthopaedic Institute","institution_ids":["https://openalex.org/I4210113750"]},{"raw_affiliation_string":"S. Paolo Hospital, Internal Medicine I, Milan, Italy","institution_ids":["https://openalex.org/I4210086830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049533356","display_name":"Norma Battafarano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086830","display_name":"Ospedale San Paolo","ror":"https://ror.org/0026m8b31","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I4210086830"]},{"id":"https://openalex.org/I4210113750","display_name":"Istituto Ortopedico Gaetano Pini","ror":"https://ror.org/02brpaf34","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210113750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"N Battafarano","raw_affiliation_strings":["Rheumatology, G. Pini Orthopaedic Institute","S. Paolo Hospital, Internal Medicine I, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology, G. Pini Orthopaedic Institute","institution_ids":["https://openalex.org/I4210113750"]},{"raw_affiliation_string":"S. Paolo Hospital, Internal Medicine I, Milan, Italy","institution_ids":["https://openalex.org/I4210086830"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112149441","display_name":"L..D. Uziel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086830","display_name":"Ospedale San Paolo","ror":"https://ror.org/0026m8b31","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I189158943","https://openalex.org/I4210086830"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"L Uziel","raw_affiliation_strings":["S. Paolo Hospital, Internal Medicine I, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Paolo Hospital, Internal Medicine I, Milan, Italy","institution_ids":["https://openalex.org/I4210086830"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064491408"],"corresponding_institution_ids":["https://openalex.org/I4210086830","https://openalex.org/I4210113750"],"apc_list":{"value":3486,"currency":"GBP","value_usd":4597},"apc_paid":null,"fwci":2.201,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.87485825,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"42","issue":"1","first_page":"193","last_page":"194"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.7329999804496765},{"id":"https://openalex.org/keywords/leflunomide","display_name":"leflunomide","score":0.8389999866485596},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.45399999618530273},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.7929999828338623},{"id":"https://openalex.org/keywords/sulfasalazine","display_name":"sulfasalazine","score":0.7730000019073486},{"id":"https://openalex.org/keywords/hydroxychloroquine","display_name":"hydroxychloroquine","score":0.8460000157356262},{"id":"https://openalex.org/keywords/kidney-failure","display_name":"renal failure","score":0.41200000047683716},{"id":"https://openalex.org/keywords/drug-induced-neutropenia","display_name":"drug-induced neutropenia","score":0.38199999928474426},{"id":"https://openalex.org/keywords/drug-induced-thrombocytopenia","display_name":"drug-induced thrombocytopenia","score":0.7070000171661377},{"id":"https://openalex.org/keywords/drug-induced-leukopenia","display_name":"drug-induced leukopenia","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9722814559936523},{"id":"https://openalex.org/C2775905006","wikidata":"https://www.wikidata.org/wiki/Q248550","display_name":"Leflunomide","level":3,"score":0.9266768097877502},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.8589134216308594},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.8494431972503662},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4699172079563141},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.4659349322319031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4058472216129303},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3255199193954468},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.13481518626213074}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077339","descriptor_name":"Leflunomide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010198","descriptor_name":"Pancytopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D013256","descriptor_name":"Steroids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/rheumatology/key051","doi":"https://doi.org/10.1093/rheumatology/key051","is_oa":false,"landing_page_url":"https://doi.org/10.1093/rheumatology/key051","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Lara D. Veeken","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},{"id":"pmid:12509641","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12509641","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology (Oxford, England)","raw_type":"Case Reports"},{"id":"pmid:29608766","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29608766","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1952461139","https://openalex.org/W2022804184","https://openalex.org/W2025103285","https://openalex.org/W2095070676","https://openalex.org/W2103310388"],"related_works":["https://openalex.org/W2025103285","https://openalex.org/W2404543745","https://openalex.org/W2614801898","https://openalex.org/W2439253061","https://openalex.org/W41463467","https://openalex.org/W57720233","https://openalex.org/W2083125534","https://openalex.org/W2895719708","https://openalex.org/W3007577435","https://openalex.org/W1978191992"],"abstract_inverted_index":{"Sir,":[0],"As":[1],"a":[2,59,122,129,166,193,231,237,249,266,281,301,314,366,417,451,489,506,665,681,765,878],"result":[3,679],"of":[4,7,16,32,43,58,102,137,145,169,195,207,236,251,263,268,305,317,321,404,406,416,453,460,480,493,498,509,523,640,664,668,673,694,730,745,762,807,820,847,883,916,959,977,1010],"the":[5,14,41,56,143,146,156,196,203,227,240,261,328,351,399,402,407,414,443,474,481,502,516,637,641,671,728,737,759,794,854,870,924,957,975,978,981,987,1011],"introduction":[6],"new":[8,642],"disease-modifying":[9],"anti-rheumatic":[10],"drugs":[11,695,836,849],"(DMARDs)":[12],"for":[13,74,202,589,700,825,923],"treatment":[15,66,115,418,890],"rheumatoid":[17],"arthritis":[18,217,252],"(RA),":[19],"patients":[20,944],"with":[21,28,62,67,116,142,260,562,596,605,619,636,720,788,834,901,907,945,989,1045,1049],"refractory":[22,946],"RA":[23,63,84,114,647,1038],"tend":[24],"to":[25,214,297,429,519,526,654,659,670,770,866,892,934,950,992,1041],"be":[26,298,688,823,941,1034,1042],"treated":[27,561,1043],"an":[29,496,646,1037],"increasing":[30],"number":[31,508,882],"different":[33],"DMARDs,":[34],"alone":[35,850],"or":[36,692,696,860,897],"in":[37,64,155,220,253,398,424,470,501,736,857,943,956,1053],"combination.":[38,1054],"This":[39,630],"improves":[40],"chances":[42],"achieving":[44],"good":[45],"disease":[46],"control":[47],"but":[48,219,280,793],"also":[49,177,354,875],"risks":[50],"triggering":[51],"adverse":[52,703,752,909],"reactions.":[53],"We":[54,686],"report":[55],"case":[57,631,710,1016],"66-yr-old":[60],"man":[61],"whom":[65],"some":[68],"recently":[69],"marketed":[70],"DMARDs":[71],"was":[72,107,152,176,212,224,245,258,292,310,331,339,343,353,391,437,448,465,476,557,594,614,650,656,698,732,921],"responsible":[73,699,824,922],"life-threatening":[75,682],"bone":[76,599,606,683,722,789,842,952,998],"marrow":[77,600,607,684,723,790,843,953,999],"toxicity.":[78],"The":[79,135,216,274,456,609,880,966],"patient's":[80],"clinical":[81,738],"history":[82,101],"included":[83],"(since":[85],"1992),":[86],"type":[87],"II":[88],"diabetes,":[89],"essential":[90],"arterial":[91],"hypertension,":[92],"chronic":[93],"urate":[94],"nephropathy":[95],"and":[96,131,159,182,184,243,287,308,336,341,383,394,505,533,543,553,560,568,578,613,627,661,675,677,725,727,773,827,830,839,936,963,974,980,1027,1047,1051],"mild":[97,322,871,960,982],"renal":[98,323,872,961],"failure.":[99,324],"No":[100],"abnormal":[103],"blood":[104,138,409,536,547,585,621,809],"cell":[105],"count":[106,205],"given.":[108],"In":[109,187,325,644],"September":[110,425],"1996,":[111],"he":[112,175,191],"started":[113,259,344],"methotrexate":[117],"(MTX)":[118],"10":[119],"mg":[120,127,364,462],"once":[121],"week,":[123,367],"folic":[124],"acid":[125],"5":[126,318,454],"twice":[128,365],"week":[130],"nimesulide":[132],"100":[133,357],"mg/day.":[134,347,386],"results":[136,403],"investigations":[139],"were":[140,411,587],"normal,":[141],"exception":[144],"erythrocyte":[147],"sedimentation":[148],"rate":[149],"(ESR),":[150],"which":[151,690,918],"32":[153],"mm":[154,397,500],"first":[157,400,457,503,657,1044],"hour,":[158],"serum":[160,289,388,490,539],"creatinine":[161,290,389,491,540],"level":[162,291,390,492],"(1.5":[163],"mg/dl":[164,393,542],"against":[165],"normal":[167],"value":[168,194],"<1.3":[170],"mg/dl).":[171],"At":[172,348],"that":[173,349,758,774,816,831,894,929,994,1001,1019],"time,":[174,350],"receiving":[178,355,478],"allopurinol":[179,374,832,964],"300":[180,375],"mg/day,":[181,358,361,370,373,376,379],"antidiabetic":[183],"antihypertensive":[185],"therapy.":[186,435],"February":[188],"1999,":[189],"as":[190,226,440,678],"had":[192,229,230,277,285,296,1002],"Disease":[197],"Activity":[198],"Score":[199],"(DAS)":[200],"modified":[201],"28-joint":[204],"[1]":[206],"4.7,":[208],"hydroxychloroquine":[209,244],"250":[210],"mg/day":[211,382],"added":[213],"MTX.":[215],"improved":[218],"April":[221],"2000":[222,255],"MTX":[223,309,338,447,655,674,821,935,1052],"discontinued":[225,299,340,438],"patient":[228,352,475,517,610,648,1039],"ureteral":[232,275],"stent":[233,276],"positioned":[234],"because":[235,304,320,663],"stone":[238],"obstructing":[239],"right":[241],"ureter,":[242],"continued":[246],"alone.":[247],"After":[248],"relapse":[250],"December":[254],"(DAS=4.8),":[256],"sulphasalazine":[257],"aim":[262],"gradually":[264],"reaching":[265],"dose":[267,316,452],"2":[269,617],"g/day":[270],"within":[271],"4":[272,771],"weeks.":[273],"been":[278,712,786,864,905,1003],"removed":[279],"small":[282,881],"fibrotic":[283],"kidney":[284],"developed,":[286],"his":[288,584],"1.6":[293],"mg/dl.":[294],"Sulphasalazine":[295],"after":[300,420,616,780,1030],"few":[302,581],"weeks":[303,618,779],"gastric":[306],"intolerance":[307],"again":[311],"prescribed":[312],"at":[313,345,450,706],"reduced":[315,507],"mg/week":[319],"June":[326],"2001,":[327,472],"rheumatic":[329],"condition":[330],"still":[332,477],"very":[333,733,804],"active":[334,760],"(DAS=5.1),":[335],"so":[337,592],"leflunomide":[342,660,715,763,895,933,972,1046],"20":[346,363,385],"atenolol":[356],"amlodipine":[359],"2.5":[360],"furosemide":[362],"phenphormine":[368],"150":[369,378],"glibenclamide":[371],"7.5":[372,551],"irbesartan":[377],"hydrochlorothiazide":[380],"12.5":[381],"rabreprazole":[384],"His":[387],"1.8":[392],"ESR":[395,497],"47":[396],"hour;":[401],"all":[405,479],"other":[408,482,835],"tests":[410,487,537],"normal.":[412],"Given":[413],"absence":[415],"response":[419],"3":[421],"months":[422],"(DAS=5.2),":[423],"2001":[426],"we":[427,926],"decided":[428],"try":[430],"anti-tumour":[431],"necrosis":[432],"factor":[433,577],"(TNF)":[434],"Leflunomide":[436],"and,":[439],"required":[441],"by":[442,899,1006],"planned":[444],"infliximab":[445,458,889,937,990,1050],"therapy,":[446],"resumed":[449],"mg/week.":[455],"infusion,":[459],"230":[461],"(3":[463],"mg/kg),":[464],"given":[466,741],"1":[467,569],"month":[468],"later":[469],"October":[471],"when":[473],"medications":[483],"described":[484],"above.":[485],"Blood":[486],"revealed":[488,602],"2.3":[494],"mg/dl,":[495],"86":[499],"hour":[504],"circulating":[510,884],"platelets":[511,554,628,885],"(125\u00d7109/l).":[512],"Ten":[513],"days":[514,582],"later,":[515,583],"came":[518],"our":[520],"department":[521],"complaining":[522],"fever":[524],"(up":[525,769],"40\u00b0C),":[527],"severe":[528,530,544,702,721,855,951],"fatigue,":[529],"ulcerative":[531],"stomatitis":[532],"dysphagia.":[534],"Urgent":[535],"showed":[538],"3.6":[541],"pancytopenia":[545,731,828,856,979],"(white":[546],"cells":[548,567,622],"1.0\u00d7109/l,":[549],"haemoglobin":[550,624],"g/dl":[552,626],"15\u00d7109/l).":[555],"He":[556],"hospitalized":[558],"immediately":[559],"transfusions":[563],"(2":[564],"U":[565,570],"red":[566],"platelets),":[571],"ceftriaxone,":[572],"fluconazole,":[573],"granulocyte":[574],"colony":[575],"stimulating":[576],"cholestyramine.":[579],"A":[580,598],"cultures":[586],"positive":[588],"Staphylococcus":[590],"epidermidisand":[591],"ceftriaxone":[593],"replaced":[595],"imipenem.":[597],"biopsy":[601],"changes":[603],"compatible":[604],"hypoplasia.":[608,685],"recovered":[611],"rapidly":[612,931],"discharged":[615],"white":[620],"6.0\u00d7109/l,":[623],"9.0":[625],"450\u00d7109/l.":[629],"indicates":[632],"what":[633],"may":[634,822,874,927,939],"happen":[635],"aggressive":[638],"use":[639],"DMARDs.":[643],"brief,":[645],"who":[649],"no":[651,914],"longer":[652],"responsive":[653],"switched":[658],"then,":[662],"continuing":[666],"lack":[667],"response,":[669],"combination":[672,693],"infliximab,":[676],"developed":[680],"cannot":[687],"sure":[689],"drug":[691,781,920],"events":[697],"this":[701,751,858,908,995,1015],"reaction.":[704,753],"Although":[705,911],"least":[707],"one":[708],"previous":[709],"has":[711,764,784],"reported":[713],"[2],":[714],"is":[716,755,814,913],"not":[717,785,940],"generally":[718],"associated":[719,787,906],"toxicity":[724,791,844,1000],"pancytopenia,":[726,925],"incidence":[729],"low":[734,818],"(0.01\u20130.1%)":[735],"trials.":[739],"However,":[740,1008],"its":[742],"antiproliferative":[743],"mechanism":[744],"action,":[746],"it":[747,813,861],"could":[748,851,862,903],"theoretically":[749],"induce":[750],"It":[754],"worth":[756],"noting":[757],"metabolite":[761],"relatively":[766,967],"long":[767,968],"half-life":[768],"weeks)":[772],"side-effects":[775],"can":[776,948],"develop":[777],"several":[778],"withdrawal.":[782],"Infliximab":[783],"either,":[792],"periodic":[795],"safety":[796],"update":[797],"reports":[798],"on":[799],"TNF-\u03b1":[800],"inhibitors":[801],"have":[802,852,863,876,904],"mentioned":[803],"rare":[805],"cases":[806],"serious":[808],"dyscrasia":[810],"[3].":[811],"Finally,":[812],"well-known":[815],"even":[817],"doses":[819],"leucopenia":[826],"[4]":[829],"interacts":[833],"(e.g.":[837],"azathioprine)":[838],"increases":[840],"their":[841,867],"[5].":[845],"Any":[846],"these":[848],"caused":[853],"case,":[859],"due":[865],"interactions;":[868],"furthermore,":[869],"failure":[873,962],"played":[877],"role.":[879],"recorded":[886,984],"just":[887,985],"before":[888,986],"seems":[891],"suggest":[893],"(alone":[896],"perhaps":[898],"interacting":[900],"MTX)":[902],"event.":[910],"there":[912],"way":[915],"knowing":[917],"specific":[919],"speculate":[928],"switching":[930],"from":[932],"(which":[938],"unusual":[942],"RA)":[947],"lead":[949],"toxicity,":[954],"especially":[955],"presence":[958],"treatment.":[965],"time":[969],"elapsed":[970],"between":[971],"discontinuation":[973],"development":[976],"thrombocytopenia":[983],"therapy":[988],"seem":[991],"indicate":[993],"agent":[996],"enhanced":[997],"already":[1004],"triggered":[1005],"leflunomide.":[1007],"regardless":[1009],"possible":[1012,1021],"pathogenetic":[1013],"mechanisms,":[1014],"warns":[1017],"us":[1018],"every":[1020],"precaution,":[1022],"including":[1023],"suitable":[1024],"washout":[1025],"periods":[1026],"cholestyramine":[1028],"administration":[1029],"leflunomide,":[1031],"should":[1032],"always":[1033],"taken":[1035],"if":[1036],"needs":[1040],"then":[1048]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}